Scribd Logo
Upload

Welcome to Scribd!

  • Merge Letter-Elijah David

    Uploaded by

    Elijah David
    5 views1 page
    The document is an invitation letter from Psycal Inc for a COVID-19 vaccine clinical trial program beginning on February 18th, 2023. The 2-week trial involves vaccination and 24-hour surveillance of participants. Only those over 18 receive $0 compensation, with a 50% bonus for those with pre-existing conditions. Participants must submit a medical questionnaire before the February 18th orientation.

    Original Description:

    Copyright

    © © All Rights Reserved

    Available Formats

    ODT, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    The document is an invitation letter from Psycal Inc for a COVID-19 vaccine clinical trial program beginning on February 18th, 2023. The 2-week trial involves vaccination and 24-hour surveillance of participants. Only those over 18 receive $0 compensation, with a 50% bonus for those with pre-existing conditions. Participants must submit a medical questionnaire before the February 18th orientation.

    Copyright:

    © All Rights Reserved
    Download as ODT, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    5 views1 page

    Merge Letter-Elijah David

    Uploaded by

    Elijah David
    The document is an invitation letter from Psycal Inc for a COVID-19 vaccine clinical trial program beginning on February 18th, 2023. The 2-week trial involves vaccination and 24-hour surveillance of participants. Only those over 18 receive $0 compensation, with a 50% bonus for those with pre-existing conditions. Participants must submit a medical questionnaire before the February 18th orientation.

    Copyright:

    © All Rights Reserved
    Download as ODT, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    of 1

    Telephone number: 1(767) 615-7456

    Email: phoenix22trials@gmail.com

    Website: The Pyscal Drug Website

    Canefield

    Riverestate

    Dear Dajjas Demha,

    We are pleased to have you aboard our Psycal COVID-19 vaccine clinical trial program. Here at
    Psycal Inc, you will be making history whilst, concurrently aiding in the elimination of the COVID-19
    virus. Furthermore, our product has been approved for testing by WHO, PAHO, and the FDA. Upon
    receiving the vaccination, you will be subject to absolute containment and 24 hour surveillance over the
    course of a two week period.
    The orientation program commences on the 18th of February, 2023 at 8am at the Pyscal Testing
    Ground in Roseau. It will end at 10am after everyone has been debriefed. The clinical trial will begin on
    the 20th of February and will last for a duration of 2 weeks.
    Only people over the age of 18 receive compensation. However, in the event the person possesses
    pre-existing, the will receive a 50% bonus on their base compensation. You will receive $0 and checks
    will be distributed at the end of the trial. Please note that you are required to fill out and submit the
    medical questionnaire before the orientation session.

    Sincerely,
    Elijah David
    Technical Director of Pyscal Clinical Trials

    You might also like